TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).
TOT BIOPHARM International Co. Ltd. has announced a change in the composition of its board committee. Dr. Liu, Weidong, who was previously the chairperson of the Remuneration Committee, has been replaced by Mr. Zhang, Qing, an independent non-executive director, to comply with the Listing Rules of the Hong Kong Stock Exchange. This change is effective from March 21, 2025, and aims to ensure the company meets regulatory requirements, potentially impacting its governance structure and investor confidence.
More about TOT BIOPHARM International Co. Ltd.
YTD Price Performance: 13.41%
Average Trading Volume: 152,560
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.61B
See more insights into 1875 stock on TipRanks’ Stock Analysis page.